Clinical Significance of Epigenetic Inactivation of hMLH1 and BRCA1 in Tunisian Patients with Invasive Breast Carcinoma

Table 4

Correlation between p53 expression level and double negative (ER^-/PR^-, ER^-/HER2^- ) and triple negative (ER^-/PR^-/HER2^-) breast cancer.

	N	ER^-/PR^-		ER^-/HER2^-		ER^-/PR^-/HER2^-
		Yes	No	Yes	No	Yes	No
P53
Positive	16	10 (62.5%)	6 (37.5%)	8 (50%)	8 (50%)	7 (43.8%)	9 (56.3%)
Negative	23	3 (13%)	20 (87%)	3 (13%)	20 (87%)	2 (8.7%)	21 (91.3%)
P (t-test)		.001		.011		.01